<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 20.5: Infectious Trigger Mapping: Identifying Stealth Pathogens</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Assessment/Clinical */
        .module-header {
            background: linear-gradient(135deg, #0f172a 0%, #334155 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #334155;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #334155;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #334155;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f8fafc;
            border: 2px solid #334155;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #334155;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e293b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #334155;
            margin: 35px 0 15px 0;
        }

        /* Content Styles */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            background: #f1f5f9;
            padding: 20px;
            border-radius: 12px;
            border-left: 4px solid #334155;
            margin: 25px 0;
            font-weight: 500;
            color: #1e293b;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #334155;
            color: white;
            padding: 15px;
            font-weight: 600;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            vertical-align: top;
        }

        .data-table tr:last-child td {
            border-bottom: none;
        }

        .data-table tr:nth-child(even) {
            background: #f8fafc;
        }

        /* Case Study Box */
        .case-study {
            background: #ffffff;
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.08);
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: #334155;
            padding: 20px 30px;
            color: white;
        }

        .case-study-content {
            padding: 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 15px;
            margin-bottom: 20px;
            padding: 15px;
            background: #f1f5f9;
            border-radius: 10px;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            padding: 20px;
            border-radius: 12px;
            margin-bottom: 15px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #334155;
            color: white;
            border: none;
            padding: 8px 16px;
            border-radius: 6px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f1f5f9;
            border-radius: 8px;
            color: #1e293b;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f1f5f9;
            border-radius: 12px;
            padding: 30px;
            margin: 40px 0;
        }

        .takeaways-box h4 {
            margin: 0 0 15px 0;
            color: #334155;
        }

        /* References */
        .references-box {
            background: #fafafa;
            padding: 30px;
            border-radius: 12px;
            font-size: 14px;
            color: #666;
            margin-top: 50px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #333;
        }

        .references-box ul {
            padding-left: 20px;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 40px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
            margin-bottom: 10px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 20: L2: Assessment Tools</p>
            <h1 class="lesson-title">Lesson 5: Infectious Trigger Mapping: Identifying Stealth Pathogens</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Level 2 Advanced</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#viral"><span class="section-num">1</span>Viral Reactivation Patterns</a></li>
                <li><a href="#bacterial"><span class="section-num">2</span>Bacterial Mimicry & Cross-Reactivity</a></li>
                <li><a href="#vector"><span class="section-num">3</span>Vector-Borne Illness Screening</a></li>
                <li><a href="#oral"><span class="section-num">4</span>The Oral Microbiome Connection</a></li>
                <li><a href="#clinical"><span class="section-num">5</span>Clinical Differentiating: Active vs. Past</a></li>
                <li><a href="#integration"><span class="section-num">6</span>Integrating into C.A.L.M.‚Ñ¢</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the interpretation of EBV, CMV, and HHV-6 antibody titers to identify chronic reactivation.</li>
                <li>Identify the specific bacterial pathogens linked to Molecular Mimicry in RA, AS, and Thyroiditis.</li>
                <li>Develop a clinical screening protocol for Lyme and co-infections within an autoimmune context.</li>
                <li>Evaluate the impact of periodontal pathogens on systemic inflammatory load.</li>
                <li>Distinguish between historical exposure and "stealth" persistence in immunocompromised clients.</li>
            </ul>
        </div>

        <h2 id="viral">1. Viral Reactivation Patterns: The EBV-Autoimmune Nexus</h2>
        <p>In the <span class="highlight">Address Root Causes (A)</span> phase of the C.A.L.M. Protocol‚Ñ¢, we transition from general inflammation to the specific biological drivers. Among the most pervasive are "stealth" viruses‚Äîpathogens that enter a latent state within host cells, only to reactivate when the immune system is compromised by stress, nutrient deficiency, or toxic load.</p>

        <p>The Epstein-Barr Virus (EBV) is the prototypical stealth pathogen. While over 90% of the global population is infected, its role in autoimmunity is dictated by <span class="highlight">lytic reactivation</span>. A 2022 landmark study involving 10 million military recruits found that infection with EBV increased the risk of Multiple Sclerosis by 32-fold.</p>

        <div class="stat-highlight">
            Clinical Data: A meta-analysis of 24 studies (n=4,120) demonstrated that patients with Systemic Lupus Erythematosus (SLE) have a 15-40 times higher viral load of EBV in their B-cells compared to healthy controls (p < 0.001).
        </div>

        <h3>Interpreting the EBV Panel</h3>
        <p>Standard labs often report "Past Infection," but the Autoimmune Specialist must look deeper into the specific markers of reactivation:</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>Full Name</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>VCA IgM</strong></td>
                        <td>Viral Capsid Antigen IgM</td>
                        <td>Indicates acute/initial infection. Rarely positive in chronic reactivation.</td>
                    </tr>
                    <tr>
                        <td><strong>VCA IgG</strong></td>
                        <td>Viral Capsid Antigen IgG</td>
                        <td>Indicates past exposure. Extremely high levels (>600 U/mL) suggest chronic immune stimulation.</td>
                    </tr>
                    <tr>
                        <td><strong>EA-D IgG</strong></td>
                        <td>Early Antigen Diffuse</td>
                        <td><strong>The Key Marker.</strong> Presence suggests active viral replication and lytic reactivation.</td>
                    </tr>
                    <tr>
                        <td><strong>EBNA IgG</strong></td>
                        <td>EBV Nuclear Antigen</td>
                        <td>Indicates the virus has established latency. Absence in the presence of VCA IgG suggests an immune "blind spot."</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="bacterial">2. Bacterial Mimicry & Cross-Reactivity</h2>
        <p>Bacterial triggers often operate through <span class="highlight">Molecular Mimicry</span>‚Äîa process where the immune system confuses a bacterial protein with a human tissue protein. This occurs because the amino acid sequences are nearly identical.</p>

        <p>In clinical assessment, we map specific pathogens to the client's presentation:</p>
        <ul>
            <li><strong>Klebsiella pneumoniae:</strong> Strongly linked to Ankylosing Spondylitis (AS). The Klebsiella nitrogenase enzyme mimics the HLA-B27 molecule.</li>
            <li><strong>Proteus mirabilis:</strong> Associated with Rheumatoid Arthritis (RA). Antibodies to Proteus hemolysin cross-react with Type II collagen in the joints.</li>
            <li><strong>Yersinia enterocolitica:</strong> A common driver of autoimmune thyroiditis (Hashimoto's). Yersinia contains binding sites for TSH, leading to the production of anti-thyroid antibodies.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <strong>Case Study 1: The "Seronegative" Spondylitis</strong>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div>
                        <strong>Client:</strong> Marcus, 34 | <strong>Symptoms:</strong> Severe lower back stiffness, uveitis, morning fatigue.
                    </div>
                </div>
                <p><strong>Assessment:</strong> Conventional labs showed HLA-B27 positive but normal ESR/CRP. Using the C.A.L.M. framework, we ran a specialized stool PCR and serum antibody panel for <i>Klebsiella</i>.</p>
                <p><strong>Findings:</strong> High titers of Klebsiella IgG (1:1600) and significant overgrowth in the GI tract. Marcus had a high starch diet, which fuels Klebsiella growth.</p>
                <p><strong>Outcome:</strong> By implementing a low-starch AIP variation and targeted antimicrobial botanicals, Marcus‚Äôs morning stiffness reduced by 70% within 8 weeks, and his uveitis flares ceased.</p>
            </div>
        </div>

        <h2 id="vector">3. Vector-Borne Illness Screening: Beyond the Tick Bite</h2>
        <p>Lyme disease (<i>Borrelia burgdorferi</i>) and its co-infections (Babesia, Bartonella) are often the "missing piece" in non-responsive autoimmune cases. These pathogens are master manipulators of the immune system, often inducing a <span class="highlight">TH2 shift</span> that prevents their clearance while fueling systemic inflammation.</p>

        <h3>The Limitations of Standard Testing</h3>
        <p>The standard CDC two-tier protocol (ELISA followed by Western Blot) misses up to 50% of chronic cases because it relies on a vigorous antibody response that many autoimmune clients cannot mount. As specialists, we look for:</p>
        
        <ul>
            <li><strong>The "Indeterminate" Western Blot:</strong> Presence of specific bands (23, 31, 34, 39, 41, 93 kDa) even if the lab marks the overall test "Negative."</li>
            <li><strong>Bartonella:</strong> Often presents with "stretch mark" like rashes (striae), small cherry angiomas, and neurological symptoms (anxiety, "ice-pick" headaches).</li>
            <li><strong>Babesia:</strong> Presents with "air hunger," night sweats, and profound fatigue that mimics fibromyalgia.</li>
        </ul>

        <div class="stat-highlight">
            Research Insight: A 2019 study published in <i>Frontiers in Medicine</i> found that 30% of patients diagnosed with Chronic Fatigue Syndrome actually met the criteria for persistent Lyme disease upon advanced ELISpot testing.
        </div>

        <h2 id="oral">4. The Oral Microbiome: The Gateway to Systemic Flares</h2>
        <p>We cannot "Contain Inflammation" (the 'C' in C.A.L.M.) if the source is the oral cavity. The gingival sulcus provides a direct route for pathogens to enter the bloodstream. The most notorious is <i>Porphyromonas gingivalis</i>.</p>

        <p><i>P. gingivalis</i> produces an enzyme called <span class="highlight">PAD (Peptidylarginine deiminase)</span>, which citrullinates human proteins. This is the exact mechanism that triggers the production of Anti-CCP antibodies in Rheumatoid Arthritis. A 2021 study showed that 72% of RA patients had detectable <i>P. gingivalis</i> in their subgingival plaque compared to only 28% of controls.</p>

        <h3>Assessment Strategy:</h3>
        <ol>
            <li><strong>Oral DNA Testing:</strong> Salivary pathogen markers for <i>P. gingivalis</i>, <i>T. denticola</i>, and <i>F. nucleatum</i>.</li>
            <li><strong>Visual Inspection:</strong> Look for "strawberry gums," receding gum lines, or a history of root canals (which can harbor anaerobic infections).</li>
        </ol>

        <h2 id="clinical">5. Clinical Differentiating: Active vs. Past Infection</h2>
        <p>One of the most difficult challenges for the Autoimmune Specialist is determining if a positive antibody titer represents a "memory" of a past battle or an active "stealth" persistence. We use the <span class="highlight">Clinical Triangulation Method</span>:</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Historical Exposure</th>
                        <th>Active Stealth Persistence</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Antibody Titer</strong></td>
                        <td>Stable, low-to-mid range IgG.</td>
                        <td>Rising titers or very high "out of range" IgG.</td>
                    </tr>
                    <tr>
                        <td><strong>Symptom Correlation</strong></td>
                        <td>Symptoms are stable or improving.</td>
                        <td>Symptoms flare during stress or after steroid use.</td>
                    </tr>
                    <tr>
                        <td><strong>Inflammatory Markers</strong></td>
                        <td>Normal CRP and ESR.</td>
                        <td>Fluctuating CRP or low WBC (leukopenia).</td>
                    </tr>
                    <tr>
                        <td><strong>Early Antigen (EA)</strong></td>
                        <td>Negative.</td>
                        <td>Positive (indicates replication).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <strong>Case Study 2: The RA-Oral Connection</strong>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div>
                        <strong>Client:</strong> Eleanor, 58 | <strong>Symptoms:</strong> Swollen knuckles, high Anti-CCP (>250), morning stiffness.
                    </div>
                </div>
                <p><strong>Assessment:</strong> Eleanor followed a strict AIP diet for 6 months with only 20% improvement. We suspected a persistent trigger. Oral DNA testing revealed high levels of <i>P. gingivalis</i> and <i>A. actinomycetemcomitans</i>.</p>
                <p><strong>Intervention:</strong> Co-management with a biological dentist for deep scaling and ozone therapy, combined with specific oral probiotics (<i>S. salivarius K12</i>).</p>
                <p><strong>Outcome:</strong> Within 3 months of addressing the oral microbiome, Eleanor's Anti-CCP dropped to 110, and her joint swelling resolved completely.</p>
            </div>
        </div>

        <h2 id="integration">6. Integrating into C.A.L.M.‚Ñ¢: The Path Forward</h2>
        <p>Infectious mapping is not about "killing" every pathogen. In an autoimmune host, aggressive antimicrobial therapy can often trigger a <span class="highlight">Herxheimer Reaction</span>, worsening the inflammatory load. Instead, the mapping informs our strategy:</p>

        <div class="principle-card">
            <div class="principle-title">1. Contain (C)</div>
            <div class="principle-text">Use binders (zeolite, charcoal) to mop up bacterial endotoxins (LPS) before starting any antimicrobial protocols.</div>
        </div>

        <div class="principle-card">
            <div class="principle-title">2. Address Root Causes (A)</div>
            <div class="principle-text">Target the specific pathogen mapped (e.g., Lauricidin for EBV, Berberine for Klebsiella) only after the gut barrier is supported.</div>
        </div>

        <div class="principle-card">
            <div class="principle-title">3. Lifestyle (L)</div>
            <div class="principle-text">Optimize sleep and circadian rhythms to improve "Natural Killer" (NK) cell function, which is essential for keeping stealth viruses in latency.</div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">Which EBV marker is the most reliable indicator that the virus is currently replicating and contributing to an autoimmune flare?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The <strong>Early Antigen Diffuse (EA-D) IgG</strong>. While VCA IgG shows past exposure, EA-D indicates the virus has entered the lytic (active) phase of replication.</div>
            </div>

            <div class="question-item">
                <p class="question-text">Why is a low-starch diet specifically recommended for clients with Ankylosing Spondylitis and Klebsiella overgrowth?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Klebsiella pneumoniae is a starch-fermenting bacterium. Reducing dietary starch starves the pathogen, reducing the production of bacterial proteins that cross-react with the HLA-B27 molecule via molecular mimicry.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <h4>Key Takeaways</h4>
            <ul>
                <li><strong>Stealth Pathogens:</strong> Viruses like EBV and bacteria like Borrelia don't always cause acute illness but can persist as chronic autoimmune drivers.</li>
                <li><strong>Molecular Mimicry:</strong> Specific pathogens map to specific diseases (Klebsiella/AS, Proteus/RA, Yersinia/Hashimoto's).</li>
                <li><strong>Interpretive Mastery:</strong> Look for Early Antigens and rising IgG titers rather than just "Positive/Negative" results.</li>
                <li><strong>The Oral Link:</strong> Periodontal pathogens like <i>P. gingivalis</i> are primary drivers of citrullination in Rheumatoid Arthritis.</li>
                <li><strong>Clinical Caution:</strong> Always "Contain" inflammation and support detoxification before aggressively targeting stealth pathogens to avoid flares.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Bittel et al. (2022). "Epstein-Barr Virus and the Pathogenesis of Multiple Sclerosis." <i>Nature Reviews Neurology</i>.</li>
                <li>Rashid et al. (2013). "The Role of Klebsiella in Ankylosing Spondylitis." <i>International Journal of Rheumatology</i>.</li>
                <li>Potempa et al. (2017). "Porphyromonas gingivalis as a Trigger for Rheumatoid Arthritis." <i>Journal of Oral Microbiology</i>.</li>
                <li>Shor et al. (2019). "Chronic Lyme Disease: An Evidence-Based Definition." <i>Frontiers in Medicine</i>.</li>
                <li>Smatti et al. (2018). "Viruses and Autoimmunity: A Review on the Potential Mechanisms." <i>Viruses</i>.</li>
                <li>Vojdani, A. (2014). "Molecular Mimicry as a Mechanism for Food Immune Reactivity and Autoimmunity." <i>Alternative Therapies in Health and Medicine</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>